Editorial: The role of combination treatment for osteoporosis

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 5, 2001, Pages 1888-1889

  Recker, Robert ^a   Heaney, Robert P ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; HORMONE DERIVATIVE; RISEDRONIC ACID; DRUG DERIVATIVE; ETIDRONIC ACID;

BONE DENSITY; COST BENEFIT ANALYSIS; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; FEMALE; HORMONE SUBSTITUTION; HUMAN; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; AGED; DRUG COMBINATION; ESTROGEN THERAPY; FRACTURE; HEALTH CARE COST; MIDDLE AGED; NOTE;

AGED; DRUG THERAPY, COMBINATION; ESTROGEN REPLACEMENT THERAPY; ETIDRONIC ACID; FEMALE; FRACTURES, BONE; HEALTH CARE COSTS; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 0035346926     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.5.1888     Document Type: Editorial

References (11)